A man shot in west Belfast at the weekend has been denied permission on anti-terrorism grounds to travel to Scotland for ...

The Phase III trial met the primary and secondary endpoints of reducing tics in children and adult patients with Tourette ...

Bayer, a global leader in radiology, announced positive results from the Phase III study QUANTI CNS, which evaluated the ...

Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopha ...

Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company” or "Plus Therapeutics”), a clinical-stage pharmaceutical company ...

Here's what MS is, what causes it and how you can expect the condition to be treated if it impacts you or someone you love.

The biopharmaceutical firm, focused on developing treatments for central nervous system diseases, posted Q4 revenue of $174.2 million, surpassing the analyst consensus of $150.24 million. However, ...

Santiago Ramón y Cajal's pioneering studies marked the beginning of a profound exploration of the complexities of the central nervous system (CNS), which ...

Interested parties may access the live and archived webcasts under the "Investors” section of the company's website at: https ...

Strong evidence for ALS often comes from familial forms of the disease, where specific gene mutations— for example in the ...